YCBD cbdmd.com: Koefisien utang jangka dawa marang modal

cbdMD, Inc. (YCBD) is expanding its cannabidiol product line, utilizing a direct-to-consumer online sales model to bypass retail costs. The business faces severe pressure from price wars amid a legal vacuum and the risk of expansion by industry behemoths. The current metric stands at 0.25. Against the backdrop of a market downturn, the firm is optimizing its distribution. This chart illustrates the price action of the asset.

For cbdMD, Inc., which is developing an extensive warehouse network in the US, the ratio of long-term liabilities to equity serves as an indicator of financial stability. This metric compares the total amount of loans with maturities exceeding one year against total shareholders' equity. It determines the extent to which business development depends on external debt financing. The stability of this ratio confirms the company's ability to maintain seamless logistics for CBD products without the risk of default. An optimal balance here guarantees expansion without a critical debt load.